Kan diabetesepidemien stanses?

Tidsskrift for den Norske Laegeforening

Volumn 116, Issue 29, 1996, Pages 3449-3450

  Joner, Geir ^a   Hanssen, Kristian F ^a  

^a AKER UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; DIABETES MELLITUS; ECONOMICS; HEALTH; HUMAN;

DIABETES MELLITUS; HUMANS; WORLD HEALTH;

EID: 0030607571     PISSN: 00292001     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. McCarty D, Zimmet P. Diabetes 1994 to 2010: global estimates and projections. Melbourne: International Diabetes Institute, 1994.
2. King H, Rewers M. Global estimates for prevalence of diabetes and impaired glucose tolerance in adults. Diabetes Care, 1993; 16: 157-77.
3. WHO Ad Hoc Diabetes Reporting Group. Diabetes and impaired glucose tolerance in women aged 20-39 years. World Health Stats Quarterly 1992; nr. 45: 321-7.
4. Joner G, Brinchmann-Hansen O, Torres CG, Hanssen KF. A nationwide cross-sectional study of retinopathy and microalbuminuria in young Norwegian type 1 diabetes patients. Diabetologia 1992; 35: 1049-54.
5. Bojestig M, Arnqvist HJ, Hermansson G, Karlberg BE, Ludvigsson J. Declining incidence of nephropathy in insulin-dependent diabetes mellitus. N Engl J Med 1994; 330: 15-8.
6. Hellesen HB, Vikane E, Lie RT, Irgens LM. Diabetes hos mor - normalisert perinatal dødelighet, men fortsatt økt fostervekst. Tidsskr Nor Lægeforen 1996; 116: 3465-9.
7. American Diabetes Association. Direct and indirect costs of diabetes in the United States in 1992. Alexandria, VA: American Diabetes Association, 1993.
8. Joner G. Insidens og prevalens av Type 1 diabetes mellitus i Norse. Norsk Epidemiologi 1994; 4: 5-9.
9. Midthjell K. Forekomsten av diabetes fire-doblet de siste 50 år. Diabetes for helsepersonell. Oslo: Norges Diabetesforbund. 1996.
10. Joner G. Ikke-genetiske ârsaksforhold ved Type I diabetes mellitus. Norsk Epidemiologi 1994; 4: 15-22.
11. WHO Study Group. Prevention of diabetes mellitus. WHO Technical Report Series 844. Genève: WHO, 1994.
12. Eriksson K-F, Lindgårde F. Prevention of type 2 (non-insulin-dependent) diabetes mellitus by diet and physical exercise. Diabetologia 1991; 34: 891-8.
13. Bingley PJ, Bonifacio E, Gale EAM. Can we really predict insulin-dependent diabetes mellitus? Diabetes 1993; 42: 213-20.
14. Mandup-Poulsen T, Reimers JI, Andersen HU, Poicot F, Karlsen AE, Bjerre U et al. Nicotinamide treatment in the prevention of insulin-depentent diabetes mellitus. Diabetes/Metabolism Reviews, 1993; 9: 295-309.
15. Rønningen KS, Spurkland A, Tait BD, Drummond B, Lopez-Larrea C, Baranda FS et al. HLA class II associations in insulin-dependent diabetes mellitus among Blacks, Caucasoids and Japanese. I: Tsui K, Aizawa M, Sasazuki T, red. HLA 1991 Oxford: Oxford University Press, 1992: 713-22.
16. Rewers M, Bugawan TL, Norris JM, Blair A, Beaty B, Hoffmann M et al. Newborn screening for HLA-markers associated with insulin-dependent diabetes mellitus. Diabetes Autoimmunity Study in the Young (DAISY). Diabetologia 1996; 39: 807-12.
17. Hanssen KF, Dahl-Jørgensen K, Brinchmann-Hansen O. Blodglukose betyr alt. Tidsskr Nor Lægeforen 1993; 113: 2890-1.